This compounded formulation, Cyclosporine 10 mg/ml/Neomycin 3.5 mg/ml/Dexamethasone 1 mg/ml/Polymyxin B 10,000 U/ml Otic Suspension, is a specialized liquid solution designed for targeted treatment of various ear conditions. It is particularly effective in managing conditions such as Otitis Externa, Acute Otitis Media, Swimmer's Ear, Chronic Otitis Media, and Malignant Otitis Externa.

The formulation combines the potent anti-inflammatory and antibacterial properties of cyclosporine, neomycin, dexamethasone, and polymyxin B. This powerful combination works synergistically to reduce inflammation, combat infection, and alleviate symptoms associated with the aforementioned ear conditions. The formulation is designed for topical administration directly to the affected area using a specific ear dropper or applicator as directed.

Cyclosporine in this formulation plays a crucial role in reducing inflammation and alleviating symptoms associated with various ear conditions. Neomycin, an antibiotic, works effectively to combat infection and minimize the risk of further complications. Dexamethasone, a steroid, further aids in reducing inflammation and alleviating symptoms. Lastly, polymyxin B, another antibiotic in the formulation, contributes to the fight against infection and helps prevent further complications.

This formulation is a safe and effective treatment option for a variety of ear-related conditions, with minimal side effects. It is a testament to the potential of compounded medications in providing targeted, effective treatment for specific conditions. If you have any questions about this formulation or how it can help treat your condition, please do not hesitate to reach out to us at Bayview Pharmacy.

Cyclosporine 10 mg/ml, Neomycin 3.5 mg/ml, Dexamethasone 1 mg/ml, and Polymyxin B 10,000 U/ml Otic Suspension is a compounded formulation specifically designed for otic use. It is intended for the treatment of various ear conditions such as Otitis Externa, Acute Otitis Media, Swimmer's Ear, Chronic Otitis Media, and Malignant Otitis Externa. This formulation provides targeted treatment, administered using a specific ear dropper or applicator as directed.

It is important to note that this formulation should not be used in patients with a known hypersensitivity to any of the components. The concomitant use of other ototoxic or nephrotoxic drugs should be avoided. Patients should be monitored for signs of nephrotoxicity or ototoxicity. Cyclosporine may increase the risk of nephrotoxicity when used with other nephrotoxic drugs. Neomycin may cause ototoxicity and should be used with caution in patients with renal impairment. Dexamethasone may increase the risk of nephrotoxicity when used with other nephrotoxic drugs. Polymyxin B may cause nephrotoxicity and ototoxicity and should be used with caution in patients with renal impairment.

If you have any questions or concerns regarding this formulation, please do not hesitate to reach out for further clarification or guidance.

This compounded formulation combines four active ingredients: Cyclosporine 10 mg/ml, Neomycin 3.5 mg/ml, Dexamethasone 1 mg/ml, and Polymyxin B 10,000 U/ml. It is an otic suspension, specifically designed for use in the ear canal to provide targeted treatment for various ear conditions. These conditions may include Otitis Externa, Acute Otitis Media, Swimmer's Ear, Chronic Otitis Media, and Malignant Otitis Externa.

Cyclosporine, an immunosuppressant, works to reduce inflammation and swelling in the ear. Neomycin and Polymyxin B, both antibiotics, are effective in fighting bacterial infections. Dexamethasone, a corticosteroid, also aids in reducing inflammation and swelling. Together, these ingredients work synergistically to treat and manage ear conditions.

The formulation is typically administered as an ear drop, using a specific ear dropper or applicator as directed by a healthcare provider. The drops should be instilled into the affected ear(s) and the ear should be gently massaged to ensure even distribution of the medication. It is important to use the drops for the duration of time prescribed by your healthcare provider to ensure the best possible outcome.

Please note that this formulation is not recommended for use in children under the age of two years. Always consult with your healthcare provider if you have any questions or concerns about this formulation or its administration.

This compounded formulation of Cyclosporine 10 mg/ml, Neomycin 3.5 mg/ml, Dexamethasone 1 mg/ml, and Polymyxin B 10,000 U/ml Otic Suspension is a liquid solution specifically designed for otic use. It provides targeted treatment for a variety of ear conditions, including infections and inflammation. The formulation is administered using a specific ear dropper or applicator as directed.

It may be used to treat a range of ear infections, including those caused by Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis. This formulation is also effective in treating chronic ear infections, which may be caused by fungal or bacterial infections. It is particularly useful in treating ear infections that have proven resistant to other treatments.

Beyond its antimicrobial properties, this formulation also helps to alleviate inflammation and itching associated with ear infections. However, it is important to note that this formulation is specifically designed for otic use and should not be used to treat other conditions, such as sinus infections or other upper respiratory tract infections.

Always consult with a healthcare professional before starting any new medication or treatment. If you have any questions or concerns about this formulation, it is recommended to seek advice from a healthcare provider.